Zhejiang Xianju Pharmaceutical Co Ltd (002332) - Total Assets

Latest as of September 2025: CN¥7.26 Billion CNY ≈ $1.06 Billion USD

Based on the latest financial reports, Zhejiang Xianju Pharmaceutical Co Ltd (002332) holds total assets worth CN¥7.26 Billion CNY (≈ $1.06 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Zhejiang Xianju Pharmaceutical Co Ltd net assets for net asset value and shareholders' equity analysis.

Zhejiang Xianju Pharmaceutical Co Ltd - Total Assets Trend (2006–2024)

This chart illustrates how Zhejiang Xianju Pharmaceutical Co Ltd's total assets have evolved over time, based on quarterly financial data.

Zhejiang Xianju Pharmaceutical Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2024)

Zhejiang Xianju Pharmaceutical Co Ltd's total assets of CN¥7.26 Billion consist of 46.6% current assets and 53.4% non-current assets.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	19.7%
Accounts Receivable	CN¥902.52 Million	12.9%
Inventory	CN¥930.86 Million	13.3%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥151.07 Million	2.2%
Goodwill	CN¥581.21 Million	8.3%

Asset Composition Trend (2006–2024)

This chart illustrates how Zhejiang Xianju Pharmaceutical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 002332 company net worth.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Zhejiang Xianju Pharmaceutical Co Ltd's current assets represent 46.6% of total assets in 2024, a decrease from 57.5% in 2006.
Cash Position: Cash and equivalents constituted 19.7% of total assets in 2024, up from 12.6% in 2006.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 10.0% of total assets, an increase from 3.0% in 2006.
Asset Diversification: The largest asset category is inventory at 13.3% of total assets.

Zhejiang Xianju Pharmaceutical Co Ltd Competitors by Total Assets

Key competitors of Zhejiang Xianju Pharmaceutical Co Ltd based on total assets are shown below.

Company	Country	Total Assets
Daihan Pharmaceutical Co.Ltd KQ:023910	Korea	₩344.02 Billion
Aurobindo Pharma Limited NSE:AUROPHARMA	India	Rs525.46 Billion
China Resources Sanjiu Medical & Pharmaceutical Co Ltd SHE:000999	China	CN¥56.56 Billion
Ningbo Menovo Pharm Co Ltd SHG:603538	China	CN¥4.75 Billion
Qianjiang Yongan Pharmaceutical Co Ltd SHE:002365	China	CN¥2.26 Billion
Zhejiang Cheng Yi Pharmaceutical Co Ltd SHG:603811	China	CN¥1.69 Billion
Hainan Honz Pharmaceutical Co SHE:300086	China	CN¥1.88 Billion
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	China	CN¥925.41 Million

Zhejiang Xianju Pharmaceutical Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	3.06	4.34	2.32
Quick Ratio	2.22	3.12	1.87
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥2.25 Billion	CN¥2.46 Billion	CN¥2.13 Billion

Zhejiang Xianju Pharmaceutical Co Ltd - Advanced Valuation Insights

This section examines the relationship between Zhejiang Xianju Pharmaceutical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.51
Latest Market Cap to Assets Ratio	0.18
Asset Growth Rate (YoY)	0.1%
Total Assets	CN¥7.00 Billion
Market Capitalization	$1.27 Billion USD

Valuation Analysis

Below Book Valuation: The market values Zhejiang Xianju Pharmaceutical Co Ltd's assets below their book value (0.18x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Zhejiang Xianju Pharmaceutical Co Ltd's assets grew by 0.1% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Zhejiang Xianju Pharmaceutical Co Ltd (2006–2024)

The table below shows the annual total assets of Zhejiang Xianju Pharmaceutical Co Ltd from 2006 to 2024.

Year	Total Assets	Change
2024-12-31	CN¥7.00 Billion ≈ $1.02 Billion	+0.10%
2023-12-31	CN¥6.99 Billion ≈ $1.02 Billion	+3.78%
2022-12-31	CN¥6.74 Billion ≈ $986.01 Million	+0.22%
2021-12-31	CN¥6.72 Billion ≈ $983.82 Million	-1.68%
2020-12-31	CN¥6.84 Billion ≈ $1.00 Billion	+17.41%
2019-12-31	CN¥5.82 Billion ≈ $852.28 Million	+7.00%
2018-12-31	CN¥5.44 Billion ≈ $796.52 Million	+6.01%
2017-12-31	CN¥5.13 Billion ≈ $751.35 Million	+41.81%
2016-12-31	CN¥3.62 Billion ≈ $529.83 Million	+5.29%
2015-12-31	CN¥3.44 Billion ≈ $503.23 Million	+22.71%
2014-12-31	CN¥2.80 Billion ≈ $410.10 Million	+1.77%
2013-12-31	CN¥2.75 Billion ≈ $402.96 Million	+12.72%
2012-12-31	CN¥2.44 Billion ≈ $357.49 Million	+21.33%
2011-12-31	CN¥2.01 Billion ≈ $294.64 Million	+10.47%
2010-12-31	CN¥1.82 Billion ≈ $266.71 Million	-2.97%
2009-12-31	CN¥1.88 Billion ≈ $274.87 Million	+62.92%
2008-12-31	CN¥1.15 Billion ≈ $168.72 Million	+10.30%
2007-12-31	CN¥1.05 Billion ≈ $152.96 Million	+6.19%
2006-12-31	CN¥984.32 Million ≈ $144.04 Million	--

About Zhejiang Xianju Pharmaceutical Co Ltd

SHE:002332 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.27 Billion

CN¥8.68 Billion CNY

Market Cap Rank

#8074 Global

#2028 in China

Share Price

CN¥8.77

Change (1 day)

-0.45%

52-Week Range

CN¥8.59 - CN¥11.58

All Time High

CN¥16.51